NSE
Dr. Agarwal's Health Care LimitedAGARWALEYE
Dr. Agarwal's Health Care Limited is an Indian company focused on providing eye care services.
| Key products | Eye care products and services |
|---|---|
| Geography | India (primarily) |
| Competitors | Cipla Ltd, Ranbaxy Laboratories Ltd |
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
—
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ATALREAL | +₹13.1 Cr | 272 | — | — | — | — |
| 2 | MOBIKWIK | +₹5.2 Cr | 355 | — | — | — | — |
| 3 | MTNL | +₹0.1 Cr | 26 | — | — | — | — |
| 4 | AGARWALEYEThis | +₹0 Cr | 8 | — | — | — | — |
| 5 | GATECH | −₹0.3 Cr | 77 | — | — | — | — |
| 6 | IRMENERGY | −₹2.2 Cr | 356 | — | — | — | — |
| 7 | QUADFUTURE | −₹7.9 Cr | 177 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Threats
- • [object Object]
- • [object Object]
AI-generated from our data — verify before relying on it.
- 2026-06-16FilingDr. Agarwal's Health Care Limited has informed the Exchange about Re-affirmation and Withdrawal of Credit RatiRating
- 2025-09-02BulkSELL · ₹71.6 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
- 2025-09-02BulkBUY · ₹71.6 CrGOLDMAN SACHS BANK EUROPE SE - ODI
- 2025-09-02BlockSELL · ₹71.6 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
- 2025-09-02BlockBUY · ₹71.6 CrGOLDMAN SACHS BANK EUROPE SE- ODI
- 2025-08-29BlockSELL · ₹18.8 CrGOLDMAN SACHS (SINGAPORE) PTE - ODI
- 2025-08-29BlockBUY · ₹18.8 CrGOLDMAN SACHS BANK EUROPE SE - ODI
- 2025-07-11BlockBUY · ₹11.9 CrBOFA SECURITIES EUROPE SA
- 2025-07-11BlockSELL · ₹11.9 CrMORGAN STANLEY ASIA SINGAPORE PTE
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 3RatingNeutral
Credit rating withdrawal by CRISIL unlikely to significantly impact share price.
Source PDF →
8 deals · 2025-07-11 → 2025-09-02
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2025-09-02 | GOLDMAN SACHS (SINGAPORE) PTE - ODI | HNI / other | SELL | ₹71.6 Cr |
| 2025-09-02 | GOLDMAN SACHS BANK EUROPE SE - ODI | HNI / other | BUY | ₹71.6 Cr |
| 2025-09-02 | GOLDMAN SACHS (SINGAPORE) PTE - ODI | HNI / other | SELL | ₹71.6 Cr |
| 2025-09-02 | GOLDMAN SACHS BANK EUROPE SE- ODI | HNI / other | BUY | ₹71.6 Cr |
| 2025-08-29 | GOLDMAN SACHS (SINGAPORE) PTE - ODI | HNI / other | SELL | ₹18.8 Cr |
| 2025-08-29 | GOLDMAN SACHS BANK EUROPE SE - ODI | HNI / other | BUY | ₹18.8 Cr |
| 2025-07-11 | BOFA SECURITIES EUROPE SA | Prop / churn | BUY | ₹11.9 Cr |
| 2025-07-11 | MORGAN STANLEY ASIA SINGAPORE PTE | HNI / other | SELL | ₹11.9 Cr |
8 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
News & chatter on AGARWALEYE
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.